Skip to main content
. 2021 Jun 28;48(8):4139–4147. doi: 10.1002/mp.14993

Table II.

Plan parameter comparisons for AUTO BAO and REF plans.

REF AUTO BAO AUTO BAO ‐ REF
Mean (min, max) Mean (min, max)
Δ
(min, max) P
PTV
D98%
34.7 (29.3, 36.8) 35.3 (32.5, 36.5) 0.6 (−1.1, 3.1) <0.001
D0.03cc
60.2 (56.0, 61.8) 59.5 (53.8, 62.5) −0.7 (−5.0, 2.6) 0.03
Urethra
D5\%
40.5 (38.8, 41.5) 40.1 (38.7, 41.7) −0.4 (−1.5, 1.8) 0.005
D10\%
40.0 (38.4, 41.1) 39.7 (38.5, 41.3) −0.4 (−1.5, 1.7) 0.005
D50\%
38.6 (35.1, 39.9) 38.1 (35.8, 39.8) −0.6 (−1.8, 1.2) <0.001
Rectum
V32.3Gy
0.5 (0.0, 1.0) 0.5 (0.0, 1.0) 0.0 (−0.5, 0.5) 0.5
D0.03cc
35.5 (32.8, 37.0) 36.4 (27.9, 38.0) 0.8 (−7.2, 3.2) <0.001
Dmean
7.2 (4.7, 9.5) 7.1 (4.2, 10.4) −0.2 (−3.6, 2.4) 0.4
Mucosa
D0.03cc
24.8 (20.7, 27.2) 24.7 (11.0, 28.1) −0.0 (−13.1, 6.8) 0.3
Bladder
V38Gy
0.3 (0.0, 0.9) 0.4 (0.0, 0.8) 0.1 (−0.3, 0.4) 0.001
D0.03cc
39.4 (37.8, 40.6) 40.0 (37.5, 41.8) 0.6 (−1.1, 2.0) <0.001
Dmean
9.1 (6.8, 12.9) 8.9 (5.4, 12.6) −0.2 (−2.1, 3.1) 0.1
Entrance
D1cc
17.3 (14.2, 19.9) 18.0 (15.3, 20.1) 0.7 (−2.8, 4.2) 0.02
Left FH
D0.03cc
13.2 (7.4, 17.6) 13.9 (5.7, 19.6) 0.7 (−6.9, 7.8) 0.2
Right FH
D0.03cc
15.1 (9.7, 18.6) 15.0 (7.0, 19.4) −0.1 (−3.3, 4.3) 0.8
Conformality 0.82 (0.75, 0.88) 0.79 (0.75, 0.87) −0.03 (−0.07, 0.02) <0.001
Beams 48.3 (37.0, 59.0) 24.7 (22.0, 25.0) −23.6 (−34.0, −12.0) <0.001
Segments 98.9 (54.0, 167.0) 59.5 (40.0, 95.0) −39.4 (−115.0, 22.0) <0.001
MU/fx [×1000] 6.1 (4.9, 8.9) 6.2 (4.9, 8.3) 0.1 (−2.7, 3.2) 0.5
ETT [min] 22.3 (17.0, 32.0) 17.1 (14.1, 22.0) −5.3 (−15.6, 1.0) <0.001

Doses (Dxx) are presented in Gy and volume (Vxx) in cc. Entrance dose was evaluated using D1cc of a ring structure of 3 cm thickness inside the patient's external contour. FH: Femoral head, MU/fx: Monitor Units per fraction, ETT: Estimated treatment time.

Bold indicates statistically significant P‐value